Metraipolis › archive › dc_fb3694a79256

Prognostic Impact of PET/CT-Derived Sarcopenia in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors — Europe PMC PMID:42194697

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42194697
DOI
10.3390/jcm15103736
License (as archived)
solo-consultazione
Archived
2026-11-02T10:54:03.698Z
SHA-256 of the archived text
f1e4e673f1b49ae5d0ae6d25114605123b5e593c781a57dd91f4b7e83ab208d5
Stable URL of this page
https://metraipolis.com/documento/dc_fb3694a79256

How to cite

Prognostic Impact of PET/CT-Derived Sarcopenia in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors — Europe PMC PMID:42194697 — Europe PMC (en), https://europepmc.org/article/MED/42194697 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fb3694a79256 (Metraipolis archive dc_fb3694a79256, sha256 f1e4e673f1b49ae5d0ae6d25114605123b5e593c781a57dd91f4b7e83ab208d5)
BibTeX
@misc{dcfb3694a79256,
  title = {Prognostic Impact of PET/CT-Derived Sarcopenia in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors — Europe PMC PMID:42194697},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42194697},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fb3694a79256; sha256 f1e4e673f1b49ae5d0ae6d25114605123b5e593c781a57dd91f4b7e83ab208d5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42194697. Agents can read the archived copy with the MCP tool read_document.